Durham, NC, United States
Durham, NC, United States

Time filter

Source Type

Research and Markets has announced the addition of the "Global Drug Discovery Technologies Market Analysis & Trends - Industry Forecast to 2025" report to their offering. The Global Drug Discovery Technologies Market is poised to grow at a CAGR of around 12.2% over the next decade to reach approximately $160 billion by 2025. This industry report analyzes the market estimates and forecasts for all the given segments on global as well as regional levels presented in the research scope. The study provides historical market data for 2013, 2014 revenue estimations are presented for 2015 and forecasts from 2016 till 2025. The study focuses on market trends, leading players, supply chain trends, technological innovations, key developments, and future strategies. Some of the prominent trends that the market is witnessing include growing identification of combinatorial chemistry technology, regulatory initiatives fostering demand for pharmacogenomics technology, proteomics in anticancer drug discovery and human protein microarray for various protein analysis. Based on technology the market is categorized into pharmacogenomics, high throughput screening, genomics, bioinformatics, biochips, bioanalytical Instruments, nanotechnology, metabolomics and other technologies. Depending on the end users the market is segmented by research institutes, pharmaceutical companies, biotech companies, biopharmaceutical companies and other end users. Depending on the Applications the market is segmented by cardiovascular diseases, cancer Parkinson's disease, central nervous system disorders and other applications. - The report provides a detailed analysis on current and future market trends to identify the investment opportunities - Market forecasts till 2025, using estimated market values as the base numbers - Key market trends across the business segments, Regions and Countries - Key developments and strategies observed in the market - Market Dynamics such as Drivers, Restraints, Opportunities and other trends - In-depth company profiles of key players and upcoming prominent players - Growth prospects among the emerging nations through 2025 - Market opportunities and recommendations for new investments 3 Market Overview 3.1 Current Trends 3.1.1 Growing identification of combinatorial chemistry technology 3.1.2 Regulatory initiatives fostering demand for pharmacogenomics technology 3.1.3 Proteomics in anticancer drug discovery 3.1.4 Human protein microarray for various protein analysis 3.2 Drivers 3.3 Constraints 3.4 Industry Attractiveness 4 Drug Discovery Technologies Market, By Technology Type 4.1 Pharmacogenomics 4.2 High Throughput Screening 4.3 Genomics 4.3.1.1 Structural Genomics 4.3.1.2 Functional Genomics 4.3.1.3 Other Genomics technologies 4.3.1.3.1.1 Clinical Medicine 4.3.1.3.1.2 New Antibiotics 4.4 Bioinformatics 4.4.1.1 Computer-Aided Drug Design 4.5 Biochips 4.5.1.1 Lab on a chip 4.5.1.2 Proteomics microarrays 4.5.1.3 DNA and Protein microarrays 4.6 Bioanalytical Instruments 4.6.1.1 Chemotherapy instruments 4.6.1.2 Mass spectrometry 4.6.1.3 Microplate readers 4.6.1.4 Nuclear magnetic resonance 4.7 Nanotechnology 4.7.1.1 Nano-mass spectroscopy 4.7.1.2 Dip-pen Nanolithography 4.7.1.3 Atomic force microscopy (AFM) 4.8 Metabolomics 4.8.1.1 Target Identification 4.8.1.2 Target Validation 4.8.1.3 Lead Optimization 4.8.1.4 Mode of Action 4.8.1.5 Preclinical Studies 4.8.1.6 Clinical Studies 4.8.1.7 Post-Approval Studies 4.8.1.8 Diagnostics 4.9 Other Technologies 4.9.1.1 RNAi (RNA interference) 4.9.1.1.1.1 MiRNAS (MicroRNA sequencing) 4.9.1.1.1.2 SiRNA (Small interfering RNA) 4.9.1.1.1.3 Other RNAi technologies 4.9.1.2 Combinatorial chemistry 4.9.1.2.1.1 Chemical Encoding 4.9.1.2.1.2 Positional Encoding 4.9.1.2.1.3 Electronic Encoding 4.9.1.3 Synthetic Biology 4.9.1.4 Proteomic 4.9.1.4.1.1 Two dimensional gel electrphoresis- 2DGE 4.9.1.4.1.2 Two-hybrid systems 4.9.1.5 Cell Based Assays 4.9.1.6 Epigenetics 4.9.1.7 Systems Biology 4.9.1.7.1.1 Computer Modelling 4.9.1.8 Quantitative polymerase chain reaction (QPCR) 4.9.1.9 Laboratory information management systems 4.9.1.10 Microfluidics 4.9.1.11 Chromatography 4.9.1.12 Protein and nucleic acid isolation 6 Drug Discovery Technologies Market, By Application 6.1 Cardiovascular Diseases 6.2 Cancer 6.3 Parkinson's disease 6.4 Central Nervous System Disorders 6.5 Other Applications 6.5.1 Other Applications Market Forecast to 2025 (US$ MN) 7 Drug Discovery Technologies Market, By Geography - Affymetrix Inc. - Tecan Group Ltd. - Sigma-Aldrich Corp - Shimadzu Corp - Perkinelmer Inc. - Thermo Fisher Scientific Inc. - Incyte Corp - Gyros AB - F. Hoffmann-La Roche Ltd. - Evotec AG - Chembridge Corp - Abbott Laboratories Inc. - Celera Corp - Caliper Life Sciences Inc. - Bio-Rad Laboratories Inc. - Astrazeneca Plc. - Albany Molecular Research Inc. - Agilent Technologies Inc. - Charles River Laboratories International Inc. - Life Technologies Corp For more information about this report visit http://www.researchandmarkets.com/research/n5klng/global_drug


News Article | December 5, 2016
Site: www.newsmaker.com.au

According to Stratistics MRC, the Global Medical Automation Technologies Market is estimated to be $52.67 billion in 2015 and is expected to reach $95.2 billion growing at a CAGR of 8.8%. The factors that are influencing the market growth include rising healthcare costs, investment by venture capitalists and the increase in use of point of care testing devices (glucose meters, digital blood pressure monitors, pregnancy test kits and HIV test kits). However the tax imposed by the U.S government on medical devices manufacturers and rigorous approval procedures to launch a product or services by companies is likely to hinder the market growth. North America is anticipated to hold the largest market share, followed by Europe. However, Asia-Pacific is expected to grow at the highest CAGR during the forecast period. Increasing aged population, growing occurrence of CVDs, diabetes, and cancer, increased funding on healthcare and life sciences research are propelling the growth of the Asia-Pacific market. Furthermore, the rising need of automation in various other medical fields represents the growth opportunities for this market. Some of the major players in the Global Medical Automation Technologies Market include GE Healthcare, Philips Healthcare, Siemens Healthcare, Tecan Group Ltd., Stanley Black and Decker, Inc., Intuitive Surgical, Inc., CAE Ltd., Brainlab AG, Given Imaging Ltd. and Medtronic, Inc. Applications Covered: • Therapeutic Automation • Lab and Pharmacy Automation • Logistics and Training Automation • Diagnostics and Monitoring Automation End Users Covered: • Research Labs and Institutes • Hospitals and Diagnostic Centers • Pharmacies • Home/Ambulatory and Others Type of Technologies Covered: • Robotic and computer-assisted surgical equipment o Surgical robots o Surgical planners and simulators o Intelligent operating rooms and related equipment o Surgical navigation systems • Automated therapeutic (non-surgical) devices o Automated medication delivery systems o Automated defibrillators • Automated prescription fulfillment devices o Dispensing machines o Intravenous compounders o Packaging machines • Automated medical imaging and image analysis o Automated microscopy o Automated radiography and fluoroscopy o Automated skin cancer detection o Automated whole-breast ultrasound o Computer-aided detection o Endoscopic capsules • Automated laboratory testing and analysis o Point-of-care Testing Systems o Central Laboratory Systems • Automated healthcare logistics, resource and patient tracking o Hospital asset/patient/staff tracking systems o Automated hospital pickup and delivery • Automated health assessment and monitoring technologies o Wearable monitors o Telehealth kiosks o Automated home monitoring and telemetry o Automated eye examination devices o Automated drug testing Regions Covered: • North America o US o Canada o Mexico • Europe o Germany o France o Italy o UK  o Spain      o Rest of Europe  • Asia Pacific o Japan        o China        o India        o Australia        o New Zealand       o Rest of Asia Pacific       • Rest of the World o Middle East o Brazil o Argentina o South Africa o Egypt What our report offers: - Market share assessments for the regional and country level segments - Market share analysis of the top industry players - Strategic recommendations for the new entrants - Market forecasts for a minimum of 7 years of all the mentioned segments, sub segments and the regional markets - Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations) - Strategic recommendations in key business segments based on the market estimations - Competitive landscaping mapping the key common trends - Company profiling with detailed strategies, financials, and recent developments - Supply chain trends mapping the latest technological advancements


News Article | December 13, 2016
Site: marketersmedia.com

Wiseguyreports.Com Adds “Medical Automation -Market Demand, Growth, Opportunities and analysis of Top Key Player Forecast to 2021” To Its Research Database According to Stratistics MRC, the Global Medical Automation Technologies Market is estimated to be $52.67 billion in 2015 and is expected to reach $95.2 billion growing at a CAGR of 8.8%. The factors that are influencing the market growth include rising healthcare costs, investment by venture capitalists and the increase in use of point of care testing devices (glucose meters, digital blood pressure monitors, pregnancy test kits and HIV test kits). However the tax imposed by the U.S government on medical devices manufacturers and rigorous approval procedures to launch a product or services by companies is likely to hinder the market growth. North America is anticipated to hold the largest market share, followed by Europe. However, Asia-Pacific is expected to grow at the highest CAGR during the forecast period. Increasing aged population, growing occurrence of CVDs, diabetes, and cancer, increased funding on healthcare and life sciences research are propelling the growth of the Asia-Pacific market. Furthermore, the rising need of automation in various other medical fields represents the growth opportunities for this market. Some of the major players in the Global Medical Automation Technologies Market include GE Healthcare, Philips Healthcare, Siemens Healthcare, Tecan Group Ltd., Stanley Black and Decker, Inc., Intuitive Surgical, Inc., CAE Ltd., Brainlab AG, Given Imaging Ltd. and Medtronic, Inc. Applications Covered: • Therapeutic Automation • Lab and Pharmacy Automation • Logistics and Training Automation • Diagnostics and Monitoring Automation End Users Covered: • Research Labs and Institutes • Hospitals and Diagnostic Centers • Pharmacies • Home/Ambulatory and Others Type of Technologies Covered: • Robotic and computer-assisted surgical equipment o Surgical robots o Surgical planners and simulators o Intelligent operating rooms and related equipment o Surgical navigation systems • Automated therapeutic (non-surgical) devices o Automated medication delivery systems o Automated defibrillators • Automated prescription fulfillment devices o Dispensing machines o Intravenous compounders o Packaging machines • Automated medical imaging and image analysis o Automated microscopy o Automated radiography and fluoroscopy o Automated skin cancer detection o Automated whole-breast ultrasound o Computer-aided detection o Endoscopic capsules • Automated laboratory testing and analysis o Point-of-care Testing Systems o Central Laboratory Systems • Automated healthcare logistics, resource and patient tracking o Hospital asset/patient/staff tracking systems o Automated hospital pickup and delivery • Automated health assessment and monitoring technologies o Wearable monitors o Telehealth kiosks o Automated home monitoring and telemetry o Automated eye examination devices o Automated drug testing Regions Covered: • North America o US o Canada o Mexico • Europe o Germany o France o Italy o UK o Spain o Rest of Europe • Asia Pacific o Japan o China o India o Australia o New Zealand o Rest of Asia Pacific • Rest of the World o Middle East o Brazil o Argentina o South Africa o Egypt What our report offers: - Market share assessments for the regional and country level segments - Market share analysis of the top industry players - Strategic recommendations for the new entrants - Market forecasts for a minimum of 7 years of all the mentioned segments, sub segments and the regional markets - Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations) - Strategic recommendations in key business segments based on the market estimations - Competitive landscaping mapping the key common trends - Company profiling with detailed strategies, financials, and recent developments - Supply chain trends mapping the latest technological advancements For more information, please visit https://www.wiseguyreports.com/sample-request/649650-medical-automation-global-market-outlook-2016-2022


Fu Y.V.,Harvard University | Yardimci H.,Harvard University | Long D.T.,Harvard University | Ho V.,State University of New York at Stony Brook | And 9 more authors.
Cell | Year: 2011

The eukaryotic replicative DNA helicase, CMG, unwinds DNA by an unknown mechanism. In some models, CMG encircles and translocates along one strand of DNA while excluding the other strand. In others, CMG encircles and translocates along duplex DNA. To distinguish between these models, replisomes were confronted with strand-specific DNA roadblocks in Xenopus egg extracts. An ssDNA translocase should stall at an obstruction on the translocation strand but not the excluded strand, whereas a dsDNA translocase should stall at obstructions on either strand. We found that replisomes bypass large roadblocks on the lagging strand template much more readily than on the leading strand template. Our results indicate that CMG is a 3′ to 5′ ssDNA translocase, consistent with unwinding via "steric exclusion." Given that MCM2-7 encircles dsDNA in G1, the data imply that formation of CMG in S phase involves remodeling of MCM2-7 from a dsDNA to a ssDNA binding mode. © 2011 Elsevier Inc.


Trademark
Tecan Group Ltd. | Date: 2014-03-11

Analytical apparatus and instruments for scientific or non-medical use, namely absorbance readers, luminescence readers, fluorescence readers, cell imaging instruments and array scanners; all the aforesaid products for laboratory use. Analytical apparatus and instruments for clinical diagnostic and veterinaric use, namely absorbance readers, luminescence readers, fluorescence readers, cell imaging instruments and array scanners; all the aforesaid products for laboratory use.


News Article | December 9, 2016
Site: marketersmedia.com

— This report studies the global Medical Automation Technologies market, analyzes and researches the Medical Automation Technologies development status and forecast in United States, EU, Japan, China, India and Southeast Asia. This report focuses on the top players in global market, like GE Healthcare Philips Healthcare Siemens Healthcare Tecan Group Ltd Stanley Black and Decker Intuitive Surgical CAE Ltd Brainlab AG Given Imaging Ltd Medtronic Awarepoint Corp Asahi Kasei CareFusion Roche Holding AG For more information or any query mail at sales@wiseguyreports.com Market segment by Application, Medical Automation Technologies can be split into Application 1 Application 2 Application 3 1 Industry Overview of Medical Automation Technologies 1.1 Medical Automation Technologies Market Overview 1.1.1 Medical Automation Technologies Product Scope 1.1.2 Market Status and Outlook 1.2 Global Medical Automation Technologies Market Size and Analysis by Regions 1.2.1 United States 1.2.2 EU 1.2.3 Japan 1.2.4 China 1.2.5 India 1.2.6 Southeast Asia 1.3 Medical Automation Technologies Market by End Users/Application 1.3.1 Application 1 1.3.2 Application 2 1.3.3 Application 3 2 Global Medical Automation Technologies Competition Analysis by Players 2.1 Medical Automation Technologies Market Size (Value) by Players (2015-2016) 2.2 Competitive Status and Trend 2.2.1 Market Concentration Rate 2.2.2 Product/Service Differences 2.2.3 New Entrants 2.2.4 The Technology Trends in Future 3 Company (Top Players) Profiles 3.1 GE Healthcare 3.1.1 Company Profile 3.1.2 Main Business/Business Overview 3.1.3 Products, Services and Solutions 3.1.4 Medical Automation Technologies Revenue (Value) (2011-2016) 3.1.5 Recent Developments 3.2 Philips Healthcare 3.2.1 Company Profile 3.2.2 Main Business/Business Overview 3.2.3 Products, Services and Solutions 3.2.4 Medical Automation Technologies Revenue (Value) (2011-2016) 3.2.5 Recent Developments 3.3 Siemens Healthcare 3.3.1 Company Profile 3.3.2 Main Business/Business Overview 3.3.3 Products, Services and Solutions 3.3.4 Medical Automation Technologies Revenue (Value) (2011-2016) 3.3.5 Recent Developments 3.4 Tecan Group Ltd 3.4.1 Company Profile 3.4.2 Main Business/Business Overview 3.4.3 Products, Services and Solutions 3.4.4 Medical Automation Technologies Revenue (Value) (2011-2016) 3.4.5 Recent Developments 3.5 Stanley Black and Decker 3.5.1 Company Profile 3.5.2 Main Business/Business Overview 3.5.3 Products, Services and Solutions 3.5.4 Medical Automation Technologies Revenue (Value) (2011-2016) 3.5.5 Recent Developments 3.6 Intuitive Surgical 3.6.1 Company Profile 3.6.2 Main Business/Business Overview 3.6.3 Products, Services and Solutions 3.6.4 Medical Automation Technologies Revenue (Value) (2011-2016) 3.6.5 Recent Developments 3.7 CAE Ltd 3.7.1 Company Profile 3.7.2 Main Business/Business Overview 3.7.3 Products, Services and Solutions 3.7.4 Medical Automation Technologies Revenue (Value) (2011-2016) 3.7.5 Recent Developments 3.8 Brainlab AG 3.8.1 Company Profile 3.8.2 Main Business/Business Overview 3.8.3 Products, Services and Solutions 3.8.4 Medical Automation Technologies Revenue (Value) (2011-2016) 3.8.5 Recent Developments 3.9 Given Imaging Ltd 3.9.1 Company Profile 3.9.2 Main Business/Business Overview 3.9.3 Products, Services and Solutions 3.9.4 Medical Automation Technologies Revenue (Value) (2011-2016) 3.9.5 Recent Developments 3.10 Medtronic 3.10.1 Company Profile 3.10.2 Main Business/Business Overview 3.10.3 Products, Services and Solutions 3.10.4 Medical Automation Technologies Revenue (Value) (2011-2016) 3.10.5 Recent Developments 3.11 Awarepoint Corp 3.12 Asahi Kasei 3.13 CareFusion 3.14 Roche Holding AG For more information or any query mail at sales@wiseguyreports.com ABOUT US: Wise Guy Reports is part of the Wise Guy Consultants Pvt. Ltd. and offers premium progressive statistical surveying, market research reports, analysis & forecast data for industries and governments around the globe. Wise Guy Reports features an exhaustive list of market research reports from hundreds of publishers worldwide. We boast a database spanning virtually every market category and an even more comprehensive collection of market research reports under these categories and sub-categories. For more information, please visit https://www.wiseguyreports.com


News Article | November 28, 2016
Site: www.newsmaker.com.au

The report "High-Throughput Screening Market by Technology (Cell-based Assays (2D & 3D Cell Culture), Lab-on-a-chip, Bioinformatics), Application (Target Identification, Primary Screening, Toxicology), Product (Reagent & Instruments), End User - Forecast to 2021" projects the market to grow at a CAGR of +7% From an insight perspective, this research report has focused on various levels of analysis—industry analysis (industry trends), market share analysis of top players, and company profiles, which together comprise and discuss the basic views on the competitive landscape; emerging and high-growth segments of the high-throughput screening market; high-growth regions; and market drivers, restraints, trends, and opportunities. Browse 237 market data tables and 39 figures spread through 252 pages and in-depth TOC on “High-Throughput Screening Market by Technology (Cell-based Assays (2D & 3D Cell Culture), Lab-on-a-chip, Bioinformatics), Application (Target Identification, Primary Screening, Toxicology), Product (Reagent & Instruments), End User - Forecast to 2021” http://www.reportsnreports.com/reports/274672-high-throughput-screening-hts-market-by-technology-cell-based-ultra-high-throughput-screening-uhts-label-free-bioinformatics-by-apllications.html The report provides insights on the following pointers: From an insight perspective, this research report has focused on various levels of analysis—industry analysis (industry trends), market share analysis of top players, and company profiles, which together comprise and discuss the basic views on the competitive landscape; emerging and high-growth segments of the high-throughput screening market; high-growth regions; and market drivers, restraints, trends, and opportunities. The high-throughput screening (HTS) market is expected to grow at a lucrative CAGR of +7% from 2016 to 2021, to reach USD 18.83 billion by 2021 from USD 12.23 billion in 2016. Market growth can be attributed to the growing adoption of open innovative models in the pharmaceutical and biotechnology industry and technological advancements like automation and miniaturization, increasing R&D spending and rising government funding. Emerging markets and growing research activities in toxicology and stem cells provide significant growth opportunities for the market. On the other hand, the high cost and time-consuming nature of HTS techniques are restraining the growth of this market during the forecast period. The global high-throughput screening market is segmented on the basis of product and service, technology, application end user and region. Based on product and service, the high-throughput screening market is segmented into consumables and reagents, instruments, & software and services. Based on technology, the high-throughput screening market is segmented into cell-based assays; lab-on-a-chip, ultra high-throughput screening market, label-free technology and bioinformatics. The cell-based assays segment is subsegmented into 2D cell culture, 3D cell culture and perfusion cell culture. 3D cell culture is further divided into scaffold-based technology (includes hydrogels and inert matrix/solid scaffolds segment) and scaffold-free technology (includes microplates, hanging-drop plates, ultra-low binding plates and others segment). The hydrogels scaffold-based technology is further subsegmented into animal-derived (includes matrigel and collagen segment), agarose/alginate and synthetic hydrogels. The other scaffold-free technology segment includes microfluidics, 3D bioreactors & magnetic levitation, and 3D bioprinting. Based on application, the HTS market is segmented into target identification, primary screening, toxicology assessment and others. The other application segment includes hospitals and clinical laboratories, food and agriculture industries, & environmental laboratories. Based on the end users, the market is classified into pharmaceutical and biotechnology companies, academic and government research institutes, contract research organizations (CROs) and other end users. The other end users segment includes hospitals & clinics, and food, agriculture, and environmental industries. Geographically, North America is the largest market for high-throughput screening, followed by Europe and Asia-Pacific. However, Asia-Pacific and Latin America possess lucrative growth potential for the high-throughput screening market during the forecast period. This is mainly attributed to the increasing R&D spending; growing trend of outsourcing drug discovery services; growing public-private partnerships; and increasing government funding. The high-throughput screening market is fragmented in nature with the presence of many small and big firms. The major players in the high-throughput screening market include Agilent Technologies, Inc. (U.S.), Danaher Corporation (U.S.), Thermo Fisher Scientific, Inc. (U.S.), PerkinElmer, Inc. (U.S.) and Tecan Group Ltd. (Switzerland), Merck Millipore (U.S.), Bio-Rad laboratories (U.S.), Hamilton Company (U.S.), Axxam S.p.A. (Italy) and Aurora Biomed (Canada). For sample copy of this report: http://www.reportsnreports.com/contacts/requestsample.aspx?name=274672 The high-throughput screening market in this report is segmented by product and service, application, technology, end user, and regions.  It provides detailed information regarding major factors influencing the growth market (drivers, restraints, opportunities, and trends). The study tracks and analyzes competitive developments such as partnerships, agreements, collaborations, acquisitions, new product developments, geographical expansions, and strategically profiles the key players and comprehensively analyzes their market shares and core competencies in the high-throughput screening market


— The report "Lab Automation Market by Equipment & Software (Robotic Arm, Microplate Readers, LIMS), Applications (Drug Discovery, Clinical Diagnostics), Type (Modular, Total Lab), & End Users (Biotechnology & Pharmaceuticals, Private Labs) - Global Forecasts to 2021" , provides a detailed overview of major drivers, restraints, challenges, opportunities, current market trends and strategies impacting the global market along with estimates and forecast of revenue. The global lab automation market is projected to reach USD 5.48 Billion by 2021 from USD 3.92 billion in 2016, at a CAGR of 6.9% from 2016 to 2021. Factors such as miniaturization of processes resulting in low reagent costs and high productivity, progressing drug discovery and clinical diagnostics, benefits of lab automation over traditional laboratory settings, government funding for biotech and drug discovery research, and shortage of laboratory professionals are the key drivers for the growth of the global lab automation market. On the other hand, lack of planning for technology development, low priority for lab automation among small and medium-sized laboratories, and indefinite data interchange/communication standards are the major factors that are restraining the growth of the lab automation market. High potential emerging markets such as China, Japan, and Middle East represents significant growth opportunities for the key players in the lab automation market. Further, the concern for reluctance to move from manual operations towards automation and lack of compatibility between systems across a laboratory may pose challenges to the growth of this market during the forecast period. The global lab automation market is segmented on the basis of equipment and software, applications, type, end users, and regions. By equipment and software, the market is categorized into automated liquid handling, microplate readers, software & informatics, standalone robots, automated storage & retrieval systems (ASRS), and other equipment & software. The automated liquid handling segment is expected to account for the largest share of the lab automation market in 2016. This large share can be attributed to the high demand for automation in liquid handling. On the basis of application the lab automation market is segmented into drug discovery, clinical diagnostics, genomics solutions, proteomics solutions, and other applications. The drug discovery application segment is expected to account for the largest share of the global lab automation market in 2016. This large share can be attributed to the need for high-/ultra-high-throughput screening and reduced time-to-market for drugs. North America is expected to account for the largest share of the lab automation market in 2016. This region is estimated to account for the largest share of the tangential flow filtration market. In this region the increase in aging population, rising prevalence of lifestyle diseases, economy stimulus programs are driving the growth of the market. However, Asian countries are expected to witness a higher growth rate. Factors such as increasing healthcare investments, large population, improving public health awareness (leading to preventative care and hence more diagnostic tests), and rising demand for standardization and accreditation are creating significant growth for the lab automation market in Asia. Major players operating in the lab automation market are Tecan Group Ltd. (Switzerland), PerkinElmer Inc. (U.S.), Thermo Fisher Scientific, Inc. (U.S.), Agilent Technologies, Inc. (U.S.), and Danaher Corporation (U.S.). For more information, please visit http://www.marketsandmarkets.com/Market-Reports/lab-automation-market-1158.html


— The report "High-Throughput Screening Market by Technology (Cell-based Assays (2D & 3D Cell Culture), Lab-on-a-chip, Bioinformatics), Application (Target Identification, Primary Screening, Toxicology), Product (Reagent & Instruments), End User - Forecast to 2021", The global high-throughput screening (HTS) market is expected to reach USD 18.83 Billion by 2021 from USD 12.23 Billion in 2016, at a CAGR of 7.8% from 2016 to 2021. The major factors driving the growth of this market include growing adoption of open innovative models in pharmaceutical and biotechnology companies and increasing R&D spending. Technological advancements in the HTS technique & rising government funding are some other factors driving the growth of this market. Emerging markets and growing research activities in toxicology and stem cells are expected to provide further growth opportunities for players operating in the market. Label-free technology and automation and miniaturization of HTS techniques are the key trends of this market. However, the high cost and time-consuming nature of HTS techniques are restraining the growth of this market during the forecast period. This market is segmented on the basis of product and service, technology, application end user and regions. Based on product and service, the global high-throughput screening market is segmented into consumables and reagents, instruments, & software and services. In 2015, consumables and reagents accounted for the largest share of the global high-throughput screening products and services market. The availability of a wide range of reagents and continual product developments and innovations contributes to their largest share in HTS products and services market. Furthermore, on the basis of end users, the market is classified into pharmaceutical and biotechnology companies, academic and government research institutes, contract research organizations (CROs) and other end users. The other end users segment includes hospitals & clinics, and food, agriculture, and environmental industries. The pharmaceutical and biotechnology companies segment accounted for the largest share in the global HTS market, by end users. The extensive use of the HTS technology in pharmaceutical and biotechnology companies for drug discovery applications is the major factor driving the growth of this market. In 2015, North America accounted for the largest share of the global high-throughput screening market, followed by Europe, Asia-Pacific, and RoW. Growth in the developed markets in North America and Europe is mainly driven by the large spending on pharmaceutical R&D and high adoption of HTS and availability of government funding, and the presence of major companies in this region. However, Asia-Pacific and Latin American regions provide wide scope for the high-throughput screening market growth. This is mainly attributed to the increasing R&D spending; growing trend of outsourcing drug discovery services; growing public-private partnerships; and increasing government funding. Agilent Technologies, Inc. (U.S.), Danaher Corporation (U.S.), Thermo Fisher Scientific, Inc. (U.S.), PerkinElmer, Inc. (U.S.) and Tecan Group Ltd. (Switzerland)held the major share of the high-throughput screening market and will continue to dominate the market between 2016 and 2021. Other major players operating in this market are Merck Millipore (U.S.), Bio-Rad laboratories (U.S.), Hamilton Company (U.S.), Axxam S.p.A. (Italy) and Aurora Biomed (Canada). For more information, please visit http://www.marketsandmarkets.com/Market-Reports/high-throughput-screening-market-134981950.html


News Article | November 24, 2016
Site: www.prnewswire.co.uk

According to a new market research report "High-Throughput Screening Market by Technology (Cell-based Assays (2D & 3D Cell Culture), Lab-on-a-chip, Bioinformatics), Application (Target Identification, Primary Screening, Toxicology), Product (Reagent & Instruments), End User - Forecast to 2021", published by MarketsandMarkets, the global market is expected to reach USD 18.83 Billion by 2021 from USD 12.23 Billion in 2016, at a CAGR of 7.8% from 2016 to 2021. Browse 237 market data Tables and 39 Figures spread through 252 Pages and in-depth TOC on "High-Throughput Screening Market" Early buyers will receive 10% customization on this report. The major factors driving the growth of this market include growing adoption of open innovative models in pharmaceutical and biotechnology companies and increasing R&D spending. Technological advancements in the HTS technique & rising government funding are some other factors driving the growth of this market. Emerging markets and growing research activities in toxicology and stem cells are expected to provide further growth opportunities for players operating in the market. Label-free technology and automation and miniaturization of HTS techniques are the key trends of this market. However, the high cost and time-consuming nature of HTS techniques are restraining the growth of this market during the forecast period. This market is segmented on the basis of product and service, technology, application end user and regions. Based on product and service, the global High-Throughput Screening Market is segmented into consumables and reagents, instruments, & software and services. In 2015, consumables and reagents accounted for the largest share of the global high-throughput screening products and services market. The availability of a wide range of reagents and continual product developments and innovations contributes to their largest share in HTS products and services market. Furthermore, on the basis of end users, the market is classified into pharmaceutical and biotechnology companies, academic and government research institutes, contract research organizations (CROs) and other end users. The other end users segment includes hospitals & clinics, and food, agriculture, and environmental industries. The pharmaceutical and biotechnology companies segment accounted for the largest share in the global HTS market, by end users. The extensive use of the HTS technology in pharmaceutical and biotechnology companies for drug discovery applications is the major factor driving the growth of this market. In 2015, North America accounted for the largest share of the global High-Throughput Screening Market, followed by Europe, Asia-Pacific, and RoW. Growth in the developed markets in North America and Europe is mainly driven by the large spending on pharmaceutical R&D and high adoption of HTS and availability of government funding, and the presence of major companies in this region. However, Asia-Pacific and Latin American regions provide wide scope for the High-Throughput Screening Market growth. This is mainly attributed to the increasing R&D spending; growing trend of outsourcing drug discovery services; growing public-private partnerships; and increasing government funding. Agilent Technologies, Inc. (U.S.), Danaher Corporation (U.S.), Thermo Fisher Scientific, Inc. (U.S.), PerkinElmer, Inc. (U.S.) and Tecan Group Ltd. (Switzerland)held the major share of the High-Throughput Screening Market and will continue to dominate the market between 2016 and 2021. Other major players operating in this market are Merck Millipore (U.S.), Bio-Rad laboratories (U.S.), Hamilton Company (U.S.), Axxam S.p.A. (Italy) and Aurora Biomed (Canada). 3D CELL CULTURE MARKET by Technology (Scaffold Based, Scaffold Free), Application (Cancer Cell Research, Cell-based Assays/Toxicity Screening), End-Users (Biotechnology & Pharmaceuticals Industries) and Geography- Global Forecast to 2021. MarketsandMarkets is the largest market research firm worldwide in terms of annually published premium market research reports. Serving 1700 global fortune enterprises with more than 1200 premium studies in a year, M&M is catering to a multitude of clients across 8 different industrial verticals. We specialize in consulting assignments and business research across high growth markets, cutting edge technologies and newer applications. Our 850 fulltime analyst and SMEs at MarketsandMarkets are tracking global high growth markets following the "Growth Engagement Model - GEM". The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write "Attack, avoid and defend" strategies, identify sources of incremental revenues for both the company and its competitors. M&M's flagship competitive intelligence and market research platform, "RT" connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets. The new included chapters on Methodology and Benchmarking presented with high quality analytical infographics in our reports gives complete visibility of how the numbers have been arrived and defend the accuracy of the numbers. We at MarketsandMarkets are inspired to help our clients grow by providing apt business insight with our huge market intelligence repository. Connect with us on LinkedIn @ http://www.linkedin.com/company/marketsandmarkets

Loading Tecan Group Ltd collaborators
Loading Tecan Group Ltd collaborators